zepbound tirzepatide patent expiration date Generic Availability & Release A Strategic Guide to Capitalizing
Description
But not everyone responded equally
RR, risk ratio
Tirzepatide is a medication that acts as a dual agonist for the GLP-1 and GIP receptors, which regulate appetite and glucose metabolism
Tirzepatide was FDA approved in May 2022 for the treatment of Type 2 diabetes
The result is a steady and significant reduction in body weight
